1. Articles 5 min read

   Pearls in the Diagnosis and Management of Rhino-Orbito-Cerebral-Mucormycosis

   “The more you know about the past, the better you are prepared for the future.” – Theodore Roosevelt 1. Elicit adequate history Considering the lethal and angio-invasive nature of Rhino-Orbital-Cerebral-Mucormycosis (ROCM) supplemented in this COVID-19 era, it is mandatory to understand the causative factors of the disease. Diabetes mellitus, oral and systemic corticosteroids, immunosuppressive drugs like tocilizumab, remdesivir, hospital admission, supplemental oxygen, mechanical ventilation, primary or secondary immunodeficiency, hematological malignancies, stem cell transplantation, solid organ malignancies and solid organ transplantation, iron overload etc have been considered the important predisposing factors. The history acts like the guiding lantern onto the path towards appropriate management. “Ignoring the signs is a good way to end up in the wrong destination” 2. Identify the Red Flag signs In-depth knowledge about the red flag signs enables the clinicians to recognize the w

   Dr. Rolika Bansal · Dr. Santosh G Honavar, MD, FACS
2. PowerPoint 1 min read

   Lasers In Ophthalmology

   Lasers In Ophthalmology

   Dr. Rutuja Talegaonkar
3. Articles 15 min read

   Trials in Glaucoma You Should Know

   Ocular Hypertension Treatment Study (OHTS) This multicentric trial recruited 1,632 patients of ocular hypertension (OHT) to answer two questions. First, if early treatment in patients of OHT with topical medication would prevent the onset of primary open-angle glaucoma (POAG). Second, which patients of OHT are more likely to develop POAG, in other words, what are the risk factors for conversion from OHT to POAG? The patients who had IOP of at least 24 mmHg in one eye and 21 mmHg in other eye, were recruited in this study. They were randomized into two groups-those who received intraocular pressure (IOP) lowering drops (Medication arm) and those who did not receive any IOP lowering drops (Observation arm). The IOP reduction was targeted at 20% in the medication group. After enrollment, patients were examined every 6-months and follow-up included a white-on-white visual field at every visit and stereoscopic disc photograph annually. The endpoint was the development of new, reproducible d

   Dr. Parveen Rewri
4. Articles 10 min read

   Ten Microbiological Facts on Mucormycosis All Ophthalmologists Should Know

   The present overview highlights major microbiological aspects of mucormycosis and attempts to increase the awareness of this ubiquitous group of fungi that are responsible for the difficult-to-manage infections presently being encountered in the setting of the ongoing COVID-19 pandemic. 1. What is Mucormycosis and why is mucormycosis emerging as a serious threat in the present COVID-19 pandemic? Mucormycosis (previously called zygomycosis; sometimes called black fungus infection) is a serious, but rare fungal infection caused by a group of molds belonging to the order Mucorales(1). Mucormycosis is a fulminant disease with high rates of morbidity and mortality that mainly affects immunocompromised patients. Depending on the location of the infection, the mucormycosis can be rhino-orbito-cerebral (most common), pulmonary, gastrointestinal, cutaneous, or disseminated. Although it has a low incidence rate, varying from 0.005 to 1.7 per million population, a sudden rise in cases of rhino-or

   Dr. A.R Anand
5. PowerPoint 1 min read

   Medical Management And Newer Drugs In Glaucoma

   Medical Management And Newer Drugs In Glaucoma

   Dr. Zahir Ansari
6. PowerPoint 1 min read

   Glaucoma Demystified

   Glaucoma Demystified

   Dr. Prachi Grover
7. Students Gallery 12 min read

   i-File: COVID-19 associated Mucormycosis

   A 53-year-old female presented to the emergency with chief complaints of drooping of the left eyelid for 3 days and sudden loss of vision in the left eye for 2 days. History of Present Illness: The patient was recovering from COVID-19 infection prior to presentation when she noticed a sudden, rapidly progressive drooping of the left eyelid over 3 days duration. It was associated with the limitation of extraocular movements. Loss of vision was sudden, associated with pain, and fullness around the eye. She had a history of the left-sided nasal block along with altered sensation over the left cheek for 1 day. She had no history of fever, toothache, trauma, hospitalization, or intake of steroids. Past Ocular History: Underwent cataract surgery in both eyes 2 years back. Past Medical History/ History of Medication: She tested COVID positive 2 weeks prior to the current presentation and was advised home quarantined. CT chest score was 3, and spO2 was maintained throughout the quarantine peri

   F( O Dr. Nisar Sonam Poonam. M.S.(ophthal) · F.M.R.F (Orbit · +1 other
8. Articles 9 min read

   Seven Tips to Treat A Treatment Resistant Microbial keratitis

   Microbial keratitis is a common potentially sight-threatening condition and is considered an ocular emergency. Managing them brings forth multiple challenges to the ophthalmologist one of them being to primarily distinguish an infective from non-infective keratitis. Based on signs, symptoms, history, and laboratory investigations a treatment plan is laid out which is modified based on clinical response and antimicrobial sensitivity. However, if the response to treatment is inadequate or the microbial keratitis is resistant to treatment it becomes mandatory to assess the factors causing it and change the therapeutic strategy accordingly. The present article attempts to look at the different factors which cause resistant microbial keratitis and means to manage them. Both local/ocular and systemic factors can contribute to the resistant nature of the ulcer and are listed in table 1. The need to address systemic concerns with the help of a physician along with the ocular factors cannot be

   Dr. Shweta Agarwal · Dr. Bhaskar Srinivasan · +1 other
9. PowerPoint 1 min read

   Mucormycosis

   Mucormycosis

   Dr. Nilanjan Chowdhury
10. PowerPoint 1 min read

    Chemotherapy in Ocular Malignancies

    Chemotherapy in Ocular Malignancies

    Dr. Fransisco Msonge

More articles